BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
월요일, 9월 14

Cogent Biosciences Inc

COGTNASDAQ
Trade with Public
Trade with Public
$33.41
N/A
가까이에: Sep 14, 5:00 PM EST
$33.41
N/A
시간외: 4:00 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Cogent Biosciences Financials

Cogent Biosciences (COGT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Cogent Biosciences Q2 EPS $(0.52) Beats $(0.57) Estimate

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.57) by 8.77 percent. This is a 1.89 percent increase over losses of $(0.53) per share from
Benzinga Newsdesk

PRO
Cogent Biosciences Q1 EPS $(0.53) Beats $(0.56) Estimate

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.56) by 5.36 percent. This is a 1.92 percent decrease over losses of $(0.52) per share from
Benzinga Newsdesk

PRO
Cogent Biosciences Q4 EPS $(0.61) Misses $(0.53) Estimate

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.53) by 15.97 percent. This is a 577.78 percent decrease over losses of $(0.09) per share
Benzinga Newsdesk

Gold Jumps Over 2%; Dole Shares Gain After Q3 Results

Avi Kapoor

S&P 500 Surges 1%; Tyson Foods Posts Upbeat Earnings

Avi Kapoor

PRO
Cogent Biosciences Q2 EPS $(0.53) Beats $(0.58) Estimate

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.58) by 9.4 percent. This is a 10.17 percent increase over losses of $(0.59) per share from
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved